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Abstract
Background: Chronic diseases cause an ever-increasing percentage of morbidity and mortality, but many have
modifiable risk factors. Many behaviors that predispose or protect an individual to chronic disease are interrelated,
and therefore are best approached using an integrated model of health and the longevity paradigm, using years
lived without disability as the endpoint.
Findings: This study used a 4-phase mixed qualitative design to create a taxonomy and related online toolkit for
the evaluation of health-related habits. Core members of a working group conducted a literature review and
created a framing document that defined relevant constructs. This document was revised, first by a working group
and then by a series of multidisciplinary expert groups. The working group and expert panels also designed a
systematic evaluation of health behaviors and risks, which was computerized and evaluated for feasibility. A
demonstration study of the toolkit was performed in 11 healthy volunteers.
Discussion: In this protocol, we used forms of the community intelligence approach, including frame analysis,
feasibility, and demonstration, to develop a clinical taxonomy and an online toolkit with standardized procedures
for screening and evaluation of multiple domains of health, with a focus on longevity and the goal of integrating
the toolkit into routine clinical practice.
Trial Registration: IMSERSO registry 200700012672
Background
As life expectancy continues rising [1], chronic diseases
are becoming increasingly prominent causes of morbid-
ity and mortality [2,3]. In high-income countries, most
leading causes of both death and disability are noncom-
municable disorders [2], many of which have well-estab-
lished, modifiable risk factors [4-6]. After adjusting for
age, these disorders cause an even greater loss of disabil-
ity-adjusted life years in low- and middle-income coun-
tries [2]. Enhanced ability to identify at-risk individuals
and modify related behavior would decrease morbidity
and mortality worldwide.
The knowledge base regarding behaviors that promote
healthy, disability-free aging continues to grow. Recent
examples include prospective cohort studies about
cognitive effects of alcohol intake [7] and adherence to a
Mediterranean diet [8,9]. Unfortunately, evidence of
health benefits of specific habits does not always trans-
late to adoption of these behaviors. For example, in a
prospective cohort study of more than 80,000 women,
only 3% fit all five criteria–not smoking, body mass
index <25, consuming ≥ 0.5 alcoholic drinks per day,
≥ 30 minutes of physical activity per day, and dietary
score within the top 40% of the cohort–that placed
them at lowest risk for cardiovascular disease; if all the
women had met these criteria, cardiovascular events
would have decreased by an estimated 82% [10].
Longevity medicine has been proposed as a proactive
approach to extending healthyl i f ee x p e c t a n c ya n dp r e -
venting chronic disease, beginning in the midlife period
of 40-65 years of age [11]. It promotes an integrated
model of health-related habits (HrH), with equal consid-
eration of behaviors that improve and that compromise
health. For most patients, primary care is the most
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begin addressing HrH. While ongoing research is inves-
tigating innovations to incorporate health promotion
into primary care [12,13], providers report barriers such
as minimal time with each patient, lack of policy-level
prioritization of health promotion, and the need to
address numerous risk factors [14]. With these limita-
tions in mind, we set out to create an online toolkit
with a formalized system to evaluate HrH, for incor-
poration into varying levels of health care. Toolkit devel-
opment was framed by a new taxonomy of HrH,
analogous to those used to classify diseases and other
health determinants (e.g. taxonomy of medical errors
[15]). Our focus was on the Spanish population. In this
report, we describe the methodology used to develop
the HrH taxonomy and accompanying toolkit, eVITAL.
Methods
Setting
This study was conducted in Antequera, Spain, by the
Spanish Association for the Scientific Study of Healthy
Aging (AECES), in a project funded by the Aging Insti-
tute (IMSERSO) of the Spanish Ministry of Health and
Social Policies http://www.imsersomayores.csic.es/.
Description of the Method
This study organizes information about HrH using long-
evity as the endpoint, with a four-phase mixed qualita-
tive approach combined with frame analysis, feasibility
and demonstration techniques to develop a toolkit
usable in primary care. The study occurred over 8 years,
as shown in Figure 1.
Phase 1: Assessment package development
Phase 1 consisted of a 4-pass approach to develop a tax-
onomy of HrH and compile a series of questionnaires
and tests of HrH concepts that can be used clinically. A
variety of expert groupings was employed during this
phase (Table 1).
Pass 1-The goal of Pass 1 was to use frame analysis to
create a document framing issues of HrH as they relate
to the desired toolkit. Frame analysis is a broadly
defined method of enumerating and defining ideas and
themes within a larger topic that is particularly useful
for defining new concepts [16]. It was applied here
because, in spite of a long history of research and focus
on healthy habits, there has been no previous attempt to
operationalize and classify these health constructs and
to build a related clinical toolkit.
T h ew o r k i n gg r o u pd e f i n e das e to fk e yc o n c e p t si n
aging with their related domains, and identified relevant
scientific references. Two core members (LSC, FA)
coordinated the literature review. They contacted 116
e x p e r t si nl o n g e v i t y ,a g i n g ,a n dr e l a t e df i e l d s .T h e s e
experts produced a critical review of each concept using
a standard procedure including Medline search. The
working group reviewed the results and organized the
international 2003 Andalusia Longevity Forum to dis-
cuss them with main experts in the field [17]. The
resulting knowledge base was published [11]. The final
key HrH domains identified were physical activity, diet,
Figure 1 Timeline of the eVITAL project.
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including sexuality, and risk behaviors, including drug
and alcohol abuse. Reviews of these HrH were updated
to include existing technical documents of IMSERSO
and used to create the framing document.
Pass 2-In Pass 2, the framing document underwent a
critical revision by the working group using a nominal
g r o u pt e c h n i q u e[ 1 7 ] .T h ep anel defined subdomains
and dimensions of the key domains identified in Pass 1,
and selected questionnaires and other tools for history-
taking and examination to be included in the formalized
assessment package. Preference was given to instru-
ments previously validated in Spanish. The group was
moderated by one of the authors (FA), whose role was
to ensure that rigorous criteria were used to select eva-
luation tools and to take notes on the proceedings,
which were later presented to participants for comments
and corrections.
Pass 3- In Pass 3, the framing document and evalua-
tion system were further developed through a series of
multidisciplinary focus group meetings. There were 4
focus groups, each moderated by members of the work-
ing group with additional expert members (Table 2). An
invitation to participate was sent to 80 participants of
the Andalusia Longevity Forum. Focus group members
included the 23 who accepted the invitation. These
groups held a series of in-person discussions, teleconfer-
ences, and personal communications. Each group was
charged with adding to the existing literature review and
the proposed definitions that pertained to its particular
area of focus, to review the proposed clinical evaluation
tools, and to prioritize areas within its domain.
Pass 4-In this final Pass, the framing document and
evaluation package were returned to the working group,
revised based on synthesis of focus group feedback, and
resent to the focus groups for a final round of comments.
Phase 2: Demonstration Study
The second phase was a qualitative demonstration study
involving 11 adult volunteers, recruited from the commu-
nity of Antequera through a health spa mailing list and
website posting. Males and females aged 40-64 were
included. Exclusion criteria included disabling chronic ill-
ness and being a current patient of a member of the work-
ing group or focus groups. Volunteers were aware of the
goal of creating an online toolkit and of the professional
backgrounds of the investigators. Evaluation occurred in
private at a local health spa. Parts of the evaluation requir-
ing little or no training were self-administered, while more
involved items were administered by members of the
working group and expert panel previously trained with
that tool. After completing the assessment package, study
participants were asked to anonymously answer 5 open-
ended questions (Additional File 1).
Results of the demonstration study were provided to
members of the working group and focus groups and
used to revise the assessment package. The final version
of eVITAL was organized into 4 levels of increasing
resource use: self-assessment (Level 0), basic primary
care (Level 1), intensive primary care (Level 2), and spe-
cialty care (Level 3).
Phase 3: Computerization of eVITAL
The assessment package was transformed into an
electronic toolkit by Conexanet SL, an information
technology business.
Table 1 Working Group Members
Name Degree Education/Training Expert Field Gender
Luis Salvador-Carulla (LSC) MD, PhD Psychiatry Mental Health Male
José Ricardo Cabo (JRC) MD, PhD Internal Medicine/Endocrinology Diet Male
Rafael Gómez (RG) MD General Medicine Sleep and sexuality Male
Carlos de Teresa (CT) MD, PhD Sports Medicine Exercise Male
Antonio Cano (AC) MD, PhD Obstetrics & gynecology Gender Male
Federico Alonso (FA) MD, PhD General Medicine Disability, Health and social policy Male
Table 2 Composition of Expert Focus Groups
Topic Moderators Rapporteur Group Member Backgrounds
Cognition LSC FA Clinical psychology (2), geriatrics, neurology, neuropsychology
Vitality and stress LSC FA Clinical psychology (2), gynecology, psychology of sexuality, psychiatry, sexuality, urology
Sleep RG FA Clinical psychology, neurophysiology, sleep medicine
Diet, exercise, & risk
behaviors
JRC FA Clinical psychology (2), nursing, physical activity, otorhinolaryngology, primary care (2),
public health
Composition of multidisciplinary focus groups by area of expertise. For fields represented more than once within a group, the number of participants is indicated
in parentheses. With the exception of the moderator of the first two groups and the rapporteur, no person is represented more than once. In total, 29 individuals
participated.
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A feasibility study involving members of the working
g r o u pa n df o c u sg r o u pw a sc o n d u c t e db a s e do nt h e3
criteria of applicability, acceptability or “user-friendli-
ness”, and practicality [18], assessed initially following
the demonstration study and again after computeriza-
tion. The questionnaire (Additional File 2) was based on
previous feasibility studies by our research group [19];
the combination of numerical and open-ended questions
was designed to maximize return rate while allowing
respondents to make any relevant comments. Responses
were not anonymous.
Ethics
One member of the working group and one member of
an expert panel, both independent of the funding
source, oversaw the ethical conduct of the study. The
study complied with the Helsinki Declaration. Ethical
approval for the study was granted by the Asociación
PSICOST, an organization dedicated to the provision of
services for people with disabilities in Spain. Demonstra-
tion study participants provided written informed
consent.
Data management and analysis
eVITAL demonstration study
Data from the volunteers were coded and maintained in
a de-identified database. Procedures for maintaining
privacy and security were registered with the General
Data Protection Registry of the Spanish Agency of Data
Protection, in accordance with Spanish Law of Data
Protection 15/1999 (LOPD) [20]. There were 5 indivi-
duals charged with managing the results of the demon-
stration study: 1 for risk habits, vitality & stress,
cognition, and mental health, 1 for exercise, 1 for diet, 1
for all other aspects, and 1 who oversaw all categories.
eVITAL feasibility study
Expert responses to the feasibility questionnaire were
compiled and summary statistics were performed. Ques-
tions with particularly low scores were considered areas
of concern warranting further review. Responses to the
open-ended questions were evaluated for trends. Experts
who suggested changes to the toolkit were contacted by
one of the authors for further discussion.
Toolkit validity
Whenever possible, evaluation items were selected that
had been previously validated in Spanish. Items without
previous Spanish validation were included with the
intention of creating data registries for future analysis.
Discussion
Longevity medicine is unique in its focus on health pro-
motion and prevention and its consideration of both
individual and public health perspectives [11]. In spite
of available evidence and awareness of the contribution
of HrH to longevity, and mounting literature on inter-
vention approaches to HrH [14], there has been no
attempt to provide a clinical taxonomy of HrH until
now. Unlike many intervention studies and existing
toolkits which focus on single health issues [21,22], this
project considers the complex relationships between
HrH in individual lifestyles. Our target demographic was
middle-adulthood, to allow for identification of risk fac-
tors while the benefits of behavior change have years to
accumulate [23]. Our protocol formalizes evaluation
procedures, progressing from a self-administered screen
to specialty care. In clinical practice, results from Levels
0 and 1 would alert clinicians to at-risk patients who
merit in-depth evaluation. Our goal was not to replace
clinical judgment, but rather to inform and guide eva-
luation of HrH.
There are several remaining steps before eVITAL is
ready for integration into routine clinical care. The
demonstration study was conducted on the non-compu-
terized assessment package, and the feasibility analysis
on the Beta-1 version of the toolkit. An equivalent
assessment must be completed with the computerized
Beta-2 version, and the results used for further revision.
Also, while the protocol included the demonstration
study of healthy volunteers in a non-medical setting, a
similar assessment has yet to be completed in medical
practice.
Our ultimate aim is to incorporate free use of eVITAL
into the primary care system in Spain and to allow
improvements and research by clinicians and other
health professionals, as well as to establish “semantic
interoperability” with other health websites. Further
work is needed to delineate appropriate treatment algo-
rithms based on evaluation results and to determine
cost-effectiveness of various sections of the toolkit. Lan-
guage-related needs include validation studies of the
inventories not previously available in Spanish and
assessments of whether the toolkit is culturally appropri-
ate for Spanish-speaking populations outside of Spain.
The toolkit is not meant to be static, but can be updated
and adapted for use in specific clinical populations.
The recent dramatic increase in available health infor-
mation has posed an enormous challenge to health
knowledge management, especially in areas like HrH
that lack a consensus on taxonomical framework, and
where international cooperation is needed to build a
comprehensive knowledge base. In this protocol, we
used forms of community intelligence to begin addres-
sing these issues for HrH. As we move forward, we
hope to develop an information model to formally
represent components of the project, to incorporate
input from broader forms of community intelligence,
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usability of the toolkit in clinical practice.
Additional file 1: Demonstration Study Questionnaire. Written
questionnaire given to adult volunteers during the Phase 2
demonstration study of the eVITAL toolkit evaluating health-related
habits.
Additional file 2: Feasibility Study Questionnaire. Questionnaire sent
to experts during the Phase 4 feasibility study of the eVITAL toolkit
evaluating health-related habits.
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